UPDATE: The UFC has issued a statement on Jon Jones’ potential USADA suspension, via MMAFighting.com.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.
Additional information will be provided at the appropriate time as the process moves forward.
Jon Jones returned to the top of the UFC world once again at UFC 21 when he defeated Daniel Cormier, but he may have thrown it all away once again.
On Tuesday, TMZ Sports reported Jones tsted positive for steroids in an in-competition drug test.
Jones reportedly tested positive for the anabolic steroid Turinabol.
Initial reports indicated Jones was being stripped of his title and that it would go back to Cormier, but there has been no official decision at the time of this writing.
The UFC light heavyweight champion was previously suspended for one year after a failed drug test leading up to UFC 200. This time around, TMZ reports Jones could face up to a four-year ban.
Jones blamed the previous failed drug test on a male sex pill, so who knows what his story will be this time around. Jones’ team has yet to comment on the situation.